Trump Unveils Vague 'Great Healthcare Plan', Replacing Subsidies With Direct Payments Critics Warn Will Harm Low-Income Americans

President Trump on Thursday unveiled a framework called the "Great Healthcare Plan" that the White House says aims to lower prescription drug costs and insurance premiums by negotiating "most-favored nation" drug deals, expanding over-the-counter access, and increasing price transparency.

“WASHINGTON (AP) —President Donald Trumpon Thursday announced the outlines of a health care plan he wants Congress to take up asRepublicans have faced increasing pressure to address rising health costsafter lawmakers letsubsidies expire”

AL

The proposal's central feature would send money directly to individuals so they can buy their own health insurance, bypassing insurers.

AL

The administration and its fact sheet describe four pillars including lowering drug prices, lowering premiums by routing aid to individuals (for example into HSAs), holding stakeholders accountable, and maximizing price transparency.

The White House presented the package as a legislative framework for Congress to act on, though officials acknowledged many details are unresolved.

Critics across multiple outlets and experts warned the plan is light on crucial implementation details, such as who would qualify, how much individuals would receive, and how payments could be spent.

They said that lack of clarity risks destabilizing Affordable Care Act marketplaces.

Al Jazeera

Health policy experts singled out the proposal's unspecified direct payments and HSA focus as potentially inadequate and harmful for lower-income enrollees.

KFF’s Cynthia Cox and other analysts noted some measures echo existing ACA transparency rules but said the plan overall lacks important details.

A central policy shift replaces enhanced ACA premium tax credits with direct payments or deposits into health savings accounts (HSAs) and restores cost-sharing reduction (CSR) payments, moves the White House says will put money directly to individuals.

“Updated on: January 15, 2026 / 1:35 PM EST/ CBS News Washington— President Trump on Thursday announced the "The Great Healthcare Plan," his long-awaited health care proposal, and asked Congress to act”

CBS News

Analysts warned these changes could have uneven effects: restoring CSRs may lower silver premiums, but HSAs are limited (they cannot be used for monthly premiums and chiefly benefit those in high-deductible plans), meaning lower-income people could be worse off.

Some research and reporting highlighted stark near-term premium pressures as the backdrop, with KFF projecting large premium increases for 2026 and raising questions about whether the plan's promised savings would be sufficient.

The plan promotes codifying a most‑favored‑nation (MFN) approach to tie U.S. prices to lower prices paid abroad.

It would curb pharmacy benefit manager (PBM) kickbacks and expand over-the-counter access.

CNBC

The White House says these measures will reduce list prices and outlays.

Supporters and the fact sheet touted potential savings.

Analysts cautioned MFN rules could undermine drug research and access to new therapies.

Other outlets flagged that enforcing price-transparency requirements on hospitals and insurers has been difficult in practice.

Reactions varied by outlet and market signals.

“President Donald Trumpunveileda multipart proposal on Thursday aimed at lowering prescription drug prices and reducing health insurance premiums, as well as increasing price transparency within the health care system”

CNN

Mainstream U.S. outlets noted the plan's political timing and lack of detail.

CNN

Financial press and West Asian reporting flagged immediate market moves, with insurer stocks rising and some drugmakers falling.

Pro-administration and alternative outlets framed the package as a major consumer win and emphasized projected taxpayer savings.

Observers across sources agreed Congress must act to implement anything in the framework.

They diverged on likely outcomes, ranging from modest bipartisan elements like transparency and PBM reforms to warnings the plan could undercut ACA protections or fail to deliver promised savings.